The Effect of Proprioceptive Neuromuscular Facilitation on Haemodynamic Responses in a Neurological Intensive Care

April 9, 2026 updated by: Alp Ozel, Abant Izzet Baysal University

The Effect of Proprioceptive Neuromuscular Facilitation on the Ankle-Brachial Index and Haemodynamic Responses in Patients in a Neurological Intensive Care Unit: A Randomised Controlled Trial

Although there are studies examining the effect of actively performed PNF exercises on haemodynamic responses in intensive care patients and healthy individuals, there are no studies investigating their effect on circulation and haemodynamic responses in unconscious patients. Therefore, this study was designed to investigate the acute effects of proprioceptive neuromuscular facilitation (PNF) exercises on peripheral circulation and haemodynamic responses in patients admitted to a neurological intensive care unit.

Hypotheses:

H1-1: Passively administered PNF exercises have beneficial effects on peripheral circulation.

H2-1: Passively administered PNF exercises have beneficial effects on haemodynamic responses.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients being monitored in the neurology intensive care unit
  • Aged 18 years or over
  • Haemodynamically stable
  • No orthopaedic condition preventing the performance of passive joint movements in the upper and lower limbs
  • A signed informed consent form from a patient's next of relative for participation in the study

Exclusion Criteria:

  • Presence of haemodynamic instability
  • Fractures, contractures or serious orthopaedic conditions in the upper or lower limbs that restrict movement
  • Diagnosis or suspicion of deep vein thrombosis
  • Severe peripheral arterial disease
  • Serious cardiac arrhythmia that may prevent exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PNF Group
Patients in the PNF group will undergo proprioceptive neuromuscular facilitation (PNF) exercises. The exercises will be performed with patients in the supine position and the head elevated by 30°.

The following PNF patterns will be applied to the upper extremity:

  • flexion - abduction - external rotation → extension - adduction - internal rotation
  • extension - abduction - internal rotation → flexion - adduction - external rotation

The following PNF patterns will be applied to the lower extremities:

  • flexion - adduction - external rotation (with the knee extended) → extension - abduction - internal rotation
  • extension - adduction - external rotation (with the knee extended) → flexion - abduction - internal rotation All exercises will be performed passively by the physiotherapist. Each movement will be performed in sets of 10-12 repetitions, with a 30-second rest period between sets.
Other Names:
  • PNF
Sham Comparator: Control Group
Patients in the control group will undergo passive range of motion (PROM) exercises in the same position.

Exercises for the upper extremities:

  • shoulder flexion - extension
  • shoulder abduction - adduction
  • shoulder internal - external rotation
  • elbow flexion - extension
  • wrist flexion - extension
  • finger flexion - extension

Exercises for the lower extremities:

  • hip flexion - extension
  • hip abduction - adduction
  • hip internal - external rotation
  • knee flexion - extension
  • ankle dorsiflexion - plantar flexion All exercises will be performed passively by the physiotherapist. Each movement will be performed in sets of 10-12 repetitions, with a 30-second rest period between sets.
Other Names:
  • PROM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ankle-Brachial İndex
Time Frame: Baseline and five or ten minutes after exercise

Systolic blood pressure will be measured at the brachial artery (upper limb) and the posterior tibial or dorsalis pedis artery (lower limb) using a Hadesco ES-101EX Doppler device, with patients in a supine resting position. The cuff will be placed at mid-arm and above the malleolus. It will be inflated until the pulse disappears and deflated slowly; the first reappearance of the pulse will be recorded as systolic pressure.

Measurements will be taken in order: same-side arm, same-side leg, opposite leg, and opposite arm. The ankle-brachial index will be calculated as the ratio of the highest lower limb systolic pressure to the highest upper limb systolic pressure.

Baseline and five or ten minutes after exercise
Heart Rate
Time Frame: Baseline and five or ten minutes after exercise
Heart rate will be recorded as beats per minute and breaths per minute, respectively, based on data obtained from the patient monitor. Measurement will be taken whilst patients are in the supine position and at rest.
Baseline and five or ten minutes after exercise
Systolic blood pressure and diastolic blood pressure
Time Frame: Baseline and five or ten minutes after exercise
Systolic and diastolic blood pressure measurements will be taken from the patient's upper extremity using an appropriately sized cuff and recorded in millimetres of mercury (mmHg). Measurement will be taken whilst patients are in the supine position and at rest.
Baseline and five or ten minutes after exercise
Respiratory rate
Time Frame: Baseline and five or ten minutes after exercise
respiratory rate will be recorded as beats per minute and breaths per minute, respectively, based on data obtained from the patient monitor. Measurement will be taken whilst patients are in the supine position and at rest.
Baseline and five or ten minutes after exercise
Peripheral oxygen saturation (SpO₂)
Time Frame: Baseline and five or ten minutes after exercise
Peripheral oxygen saturation (SpO₂) will be measured using a pulse oximeter. Measurement will be taken whilst patients are in the supine position and at rest.
Baseline and five or ten minutes after exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate Pressure Product
Time Frame: Baseline and five or ten minutes after exercise
Rate Pressure Product is calculated by dividing the product of heart rate and systolic blood pressure by 1,000
Baseline and five or ten minutes after exercise
Quadriceps circumference measurement
Time Frame: Baseline and five or ten minutes after exercise

Measurements will be taken whilst patients are in the supine position or, where appropriate, in a seated position. During the measurement, a non-elastic tape measure will be used to measure the circumference at the widest part of the thigh. The tape measure will be placed parallel to the thigh circumference, and the measurement result will be recorded in centimetres (cm).

To enhance the reliability of the measurement, two separate measurements will be taken for each patient, and the average of the obtained values will be used in the analyses.

Baseline and five or ten minutes after exercise
Oxford Acute Severity of Illness Score
Time Frame: Baseline and five or ten minutes after exercise
Oxford Acute Severity of Illness Score comprises a total of 10 parameters: age, heart rate, mean arterial pressure, respiratory rate, body temperature, Glasgow Coma Scale, urine output, mechanical ventilation status, length of stay in intensive care, and the presence of elective surgery. Each parameter is assessed according to specific score ranges, and the total score indicates the severity of the illness. Higher scores indicate a higher risk of mortality.
Baseline and five or ten minutes after exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 15, 2026

Primary Completion (Estimated)

January 15, 2027

Study Completion (Estimated)

May 15, 2027

Study Registration Dates

First Submitted

April 3, 2026

First Submitted That Met QC Criteria

April 9, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AIBU-FTR-BS-002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurologic Disorder

Clinical Trials on Proprioceptive Neuromuscular Facilitation Exercises

Subscribe